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Abstract
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Prior studies have identified the associations between environmental phenol and paraben
exposures and increased risk of gestational diabetes mellitus (GDM), but no study addressed these
exposures as mixtures. As methods have emerged to better assess exposures to multiple chemicals,
our study aimed to apply Bayesian kernel machine regression (BKMR) to evaluate the association
between phenol and paraben mixtures and GDM.
This study included 64 GDM cases and 237 obstetric patient controls from the University
of Oklahoma Medical Center. Mid-pregnancy spot urine samples were collected to quantify
concentrations of bisphenol A (BPA), benzophenone-3, triclosan, 2,4-dichlorophenol, 2,5dichlorophenol, butylparaben, methylparaben, and propylparaben. Multivariable logistic regression
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was used to evaluate the associations between individual chemical biomarkers and GDM while
controlling for confounding. We used probit implementation of BKMR with hierarchical variable
selection to estimate the mean difference in GDM probability for each component of the phenol
and paraben mixtures while controlling for the correlation among the chemical biomarkers.
When analyzing individual chemicals using logistic regression, benzophenone-3 was positively
associated with GDM [adjusted odds ratio (aOR) per interquartile range (IQR) = 1.54, 95%
confidence interval (CI) 1.15, 2.08], while BPA was negatively associated with GDM (aOR
0.61, 95% CI 0.37, 0.99). In probit-BKMR analysis, an increase in z-score transformed log
urinary concentrations of benzophenone-3 from the 10th to 90th percentile was associated with an
increase in the estimated difference in the probability of GDM (0.67, 95% Credible Interval 0.04,
1.30), holding other chemicals fixed at their medians. No associations were identified between
other chemical biomarkers and GDM in the BKMR analyses.

Author Manuscript

We observed that the association of BPA and GDM was attenuated when accounting for
correlated phenols and parabens, suggesting the importance of addressing chemical mixtures in
perinatal environmental exposure studies. Additional prospective investigations will increase the
understanding of the relationship between benzophenone-3 exposure and GDM development.
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Introduction
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Gestational diabetes mellitus (GDM), defined as glucose intolerance with onset or first
recognition during pregnancy (Carpenter and Coustan, 1982), is a common pregnancy
complication that can lead to various adverse perinatal and maternal outcomes, including
spontaneous abortion, fetal anomalies, intrauterine fetal demise, and preeclampsia
(American Diabetes Association (ADA), 2016). Additionally, the long-term impact of GDM
after the obstetrical and neonatal periods is recognized as mothers and their offspring are
at increased risk of obesity and subsequent type 2 diabetes (T2DM) (Damm et al., 2016).
According to the 2016 National Vital Statistics Birth Data, the crude national prevalence of
GDM in the United States (US) was 6.0% (Deputy et al., 2018). In addition, diagnoses of
GDM increased from age-standardized estimates of 47.6 to 63.5 per 1000 live births from
2011 to 2019 among nulliparous women aged 15 to 44 years with a singleton live birth
in the US (Shah et al., 2021). Although maternal age, race/ethnicity, diet, and obesity are
established risk factors for GDM (Zhang et al., 2016), the etiology of GDM remains unclear.
As diabetes pathogenesis is potentially accelerated under the diabetogenic conditions of
pregnancy (Torgersen and Curran, 2006), further clarity is needed regarding the possible
involvement of multiple environmental chemicals in GDM development during this critical
window of susceptibility.
Usage of phenols and parabens in food production, personal and home care, and
medical-care products is ubiquitous (Sargis and Simmons, 2019). By acting as endocrinedisrupting chemicals (EDCs), these chemicals may play an important role in interfering
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with glucose homeostasis through various potential mechanisms during the susceptible
period of pregnancy; therefore, they are suspected risk factors for GDM (Gaston et al.,
2020). For example, animal studies have revealed that phenols and parabens alter the
activity or expression of the peroxisome proliferator-activated receptors (PPARs), affecting
adipogenesis and energy balance (Taxvig et al., 2012). In addition, phenols and parabens
participate in controlling microRNA expression in trophoblast cells and sequentially induce
exosome signaling from the placenta, which mediates GDM development (Ehrlich et al.,
2016). Numerous epidemiological studies have examined the associations of certain phenols
and parabens with elevated pregnancy glucose levels (Bellavia et al., 2018; Bellavia et al.,
2019; Chiu et al., 2017; Wang et al., 2020) and GDM (Fisher et al., 2018; Li et al., 2019;
Liu et al., 2019; Ouyang et al., 2018; Robledo et al., 2013; Shapiro et al., 2018; Shapiro
et al., 2015; Wang et al., 2017; Zhang et al., 2019), with inconclusive results. However,
most studies have only examined the associations of one chemical with GDM at a time.
In reality, pregnant women are exposed to multiple environmental chemicals (Wang et al.,
2021). Therefore, exploring the health impact of individual chemicals does not adequately
represent the complexity of realistic exposures.

Author Manuscript
Author Manuscript

Although assessments of exposure to multiple chemicals have emerged, no study to date has
explored the associations between phenol and paraben mixtures and the perinatal diagnosis
of GDM. Pregnant women may be more susceptible to EDC-induced changes in pancreatic
islets under the influence of pregnancy hormones (Sargis and Simmons, 2019). Thus,
understanding the effect of phenols and parabens on GDM is of interest. In the present study,
we aimed to implement a novel probit extension of Bayesian kernel machine regression
(BKMR) to investigate the association of phenol and paraben mixtures with GDM. To
compare results with prior studies evaluating individual chemical exposure biomarkers, our
study additionally evaluated the associations between individual phenols and parabens and
GDM using conventional logistic regression models.

2
2.1

Materials and Methods
Study design and population

Author Manuscript

In this clinic-based case-control study, we enrolled 314 pregnant women who received
prenatal care at the University of Oklahoma Medical Center Women’s Clinic and High-Risk
Pregnancy Clinics between August 2009 and May 2010. As described previously (Chen et
al., 2021), the women included in the study were aged 18 years or older, attended their
first clinic visit following glucose screening, did not report a pre-existing diagnosis of
type 1 or type 2 diabetes, spoke English or Spanish, and resided within the nine counties
surrounding the clinic. Restricting cases and controls to clinic patients who lived in the
catchment area aimed to select controls from the same source population that generated the
cases. Our analyses were restricted to 301 pregnant women who had stored urine available
for quantification of phenol and paraben concentrations. The characteristics of the study
participants did not differ between women who did and did not have urine specimens
available.
The GDM diagnosis was assessed based on a two-step approach (Carpenter and Coustan,
1982), 1-hour 50-g glucose challenge test (GCT) followed by 3-hour 100-g oral glucose
Environ Res. Author manuscript; available in PMC 2022 November 01.
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tolerance test (OGTT), which was in accordance with the clinical practice guidelines
followed by the recruitment clinics when the study was conducted. Pregnant women were
identified as having GDM (n = 64) if their GCT screening value was ≥ 200 mg/dL; or
had an initial GCT screening ≥ 135 mg/dL, followed by the OGTT screening with two
or more values exceeding 95 mg/dL, 180 mg/dL, 165 mg/dL, and 145 mg/dL, at fasting,
1-hour, 2-hour, 3-hour post-OGTT, respectively (Carpenter and Coustan, 1982). Pregnant
women who tested negative for GDM were concurrently selected as controls (n = 237). All
participants provided informed consent for their urine specimens to be collected and stored
for analysis in this study. This study was approved by the Institutional Review Board of the
University of Oklahoma Health Sciences Center [parent study participation and storage of
specimens for future research (#14738, 7/16/2009) and current project involving secondary
data analysis (#2477, 7/27/2010)]. The analysis of de-identified specimens at the Centers
for Disease Control and Prevention (CDC) laboratory was determined not to constitute
engagement in human subjects’ research.

Author Manuscript

2.2

Quantification of urinary phenols and parabens
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Mid-pregnancy urine samples (median: 26.0 gestational weeks) were collected at enrollment
in sterile polypropylene containers and stored at −20 °C. In November 2011, the frozen
urine samples were shipped overnight to the CDC’s National Center for Environmental
Health, Division of Laboratory Sciences for analysis. As described previously (Ye et al.,
2006; Ye et al., 2005), urinary concentrations of the following five phenols [bisphenol
A (BPA), benzophenone-3, triclosan, 2,4-dichlorophenol, 2,5-dichlorophenol] and three
parabens (butylparaben, methylparaben, and propylparaben) were quantified by online solidphase extraction coupled with isotope dilution-high-performance liquid chromatographytandem mass spectrometry. The limits of detection (LODs) were 0.2 (2,4-dichlorophenol,
2,5-dichlorophenol, butylparaben, and propylparaben), 0.4 (BPA and benzophenone-3), 1.0
(methylparaben), and 2.3 (triclosan) ng/mL. A value equal to the LOD/√2 was substituted for
biomarker concentrations below the LOD (Hornung and Reed, 1990).

Author Manuscript

Specific gravity (SG) was measured by a calibrated hand-held refractometer at the time
of urine sample collection to adjust for variations in urine diluteness. We adjusted the
urinary concentrations based on the approach that incorporates both covariate-adjusted
standardization and the inclusion of SG as a covariate in the regression model (O’Brien
et al., 2016). The formula for covariate-adjusted standardization is given as SG-adjusted
chemical concentration (ng/mL) = observed chemical concentration × [(SGp−1)/(SGo−1)],
where SGp and SGo are the predicted SG and observed SG for each observation, respectively
(Kuiper et al., 2021). SGp was estimated by employing a prediction model with SGo, with
the following factors known to affect SG: age, race/ethnicity, and pre-pregnancy body mass
index (BMI) (Kuiper et al., 2021).
2.3

Covariates Measurement
All participants completed a short interview at enrollment for collection of data on
demographic, behavioral, and medical characteristics. The factors evaluated included
maternal age, race/ethnicity, educational level, parity, and history of GDM. Pre-pregnancy
BMI (kg/m2) was calculated using self-reported pre-pregnancy height and weight. Alcohol
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consumption (yes/no) was defined as having ever consumed an alcoholic beverage during
the first trimester. Pregnant women were defined as active smokers (yes/no) if they selfreported as currently smoking or had a urinary cotinine concentration greater than 15
ng/mL (Benowitz et al., 2009). The detailed measures of each covariate have been described
previously (Chen et al., 2021).
2.4

Statistical Analyses

Author Manuscript

Demographic characteristics, lifestyle factors, and GDM history were summarized using
percentages. Comparisons of characteristics between GDM cases and controls were
conducted using Chi-square tests. The SG-adjusted urinary concentrations of phenols
and parabens of cases and controls were summarized using geometric mean (GM) of
concentrations with 95% confidence interval (CI) and 25th, 50th, and 75th percentiles.
Differences in the geometric mean between cases and controls were evaluated using
Student’s t-tests of the arithmetic means of the log-transformed values. Pairwise correlations
among the five phenols and three parabens were assessed using Pearson’s correlation for the
log-transformed values.

Author Manuscript

Multivariable logistic regression models were applied to estimate odds ratios (ORs) and
95% CIs for the associations of individual SG-adjusted urinary concentrations of phenols
and parabens with GDM while controlling for potential confounders. Both continuous and
categorical measures of individual biomarker concentrations were assessed in the models.
For continuous measures, we evaluated the ORs per interquartile range (IQR) increase in
the log-transformed concentrations of each chemical. For categorical measures, the urinary
concentrations were classified into tertiles based on the control distribution, and the lowest
tertile was used as the reference group. Due to the relatively low detection frequency of
butylparaben, we classified butylparaben concentrations as non-detectable, being below the
median of detectable concentrations among controls, or greater than or equal to the median
of detectable concentrations. The linear trend of ORs was determined by treating each
tertile as an ordinal variable in the models and reported its p-value. Since prior studies
have suggested that pre-pregnancy BMI may modify the associations of certain phenols and
parabens with GDM (Bellavia et al., 2018; Li et al., 2019; Liu et al., 2019; Wang et al.,
2020; Zhang et al., 2019), we explored this potentially differential effect by conducting a
stratified analysis by the obesity status.

Author Manuscript

This study used the manual forward selection approach in multivariable modeling to
evaluate the potential confounding variables (Lash et al., 2021), since the number of
events in this study population was too limited to evaluate a model that included all
covariates simultaneously. The forward selection procedures start with a minimal model that
includes only the exposure variable, followed by subsequent models that systematically add
covariates to evaluate the evidence for confounding. Covariates were defined as confounders
when the exposure ORs changed by approximately 10% or beyond when comparing the
models with and without adjustment for the selected factor. To maximize the number
of covariates that could be supported by the number of GDM events in our logistic
regression models, we selected the covariates with the fewest categories if the change in the
exposure OR was similar for different specifications of the same covariate. We identified the
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following variables as potential confounders of the associations between phenols, parabens,
and GDM: maternal age (continuous measure), race/ethnicity (Non-Hispanic White/Others,
Non-Hispanic Black, or Hispanic), education level (less than high school versus high
school graduate or beyond), pre-pregnancy BMI (obese or not obese), and history of GDM
(nulliparous or parous without GDM history versus parous with GDM history).

Author Manuscript
Author Manuscript
Author Manuscript

The effect of exposure to multiple phenols and parabens on GDM was performed using
BKMR, a nonparametric approach for estimating multiexposure mixtures that flexibly
models the joint effect of the mixture using the kernel function (Bobb et al., 2018; Bobb et
al., 2015; Valeri et al., 2017). BKMR can be extended to analyze the association between
mixtures and a binary outcome by implementing the probit link function. Using probit
regression in BKMR (probit-BKMR), we can estimate the exposure-response function
between biomarker concentrations and a latent continuous outcome, a continuous marker
of the binary outcome, indicating the estimated difference in the probability of the outcome
(Bobb et al., 2018). To accommodate correlation structures within phenols and parabens,
we fitted probit-BKMR with a hierarchical variable selection approach to account for the
correlation of the mixture components. According to the results of the exploratory factor
analysis (EFA), we classified the phenols and parabens into five groups: dichlorophenols
(2,4-dichlorophenol and 2,5-dichlorophenol), parabens (butylparaben, methylparaben, and
propylparaben), BPA, benzophenone-3, and triclosan, respectively. The kernel function was
specified as the Gaussian kernel when fitting the probit-BKMR models in the present study
(Bobb et al., 2015; Valeri et al., 2017). We fitted the probit-BKMR model using the Markov
chain Monte Carlo (MCMC) algorithm with 100,000 iterations in the R package ‘bkmr’.
To ensure the comparability of the exposure variables, all log-transformed concentrations
of SG-adjusted phenols and parabens were standardized to create z-scores when fitting the
models. The confounders identified in the models evaluating individual chemical biomarkers
were controlled for in the probit-BKMR models. Estimates of the exposure-response
function and its uncertainty quantified as credible intervals (CrI) were obtained after fitting
the probit-BKMR models. We characterized the estimated exposure-response function as
follows: The dose-response relationships of each chemical biomarker with GDM were
visualized by plotting the estimated difference in the probability of GDM against each
z-score-transformed phenol and paraben concentrations while fixing other chemicals at their
median levels. The single-exposure effects of each chemical on GDM were summarized as
the estimated difference in the probability of GDM when a particular phenol and paraben
concentration was increased from the 10th to the 90th percentile with other phenols and
parabens fixed to their 25th, 50th, or 75th percentile. The overall effects of the phenol and
paraben mixtures were represented as the estimated difference in the probability of GDM
when all the mixtures were at a particular percentile ranging from the 10th to the 90th
percentile and compared to the mixtures at the median levels. The interactive effects were
presented as bivariate exposure-response functions between a certain phenol and paraben
and the estimated difference in the probability of GDM when a second phenol and paraben
concentration was at the 10th, 50th, or 90th percentile, while fixing other chemicals at their
median levels. A formal interaction test by adding product terms to the logistic regression
models was conducted for the presence of potential effect modification.
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All statistical analyses were conducted using SAS version 9.4 (SAS Institute, Cary, NC,
USA) and R version 4.0.2 (R Core Team, 2020). Two-sided p-values < 0.05 were considered
statistically significant.

3
3.1

Results
Basic characteristics of study participants

Author Manuscript

Table 1 displays the demographics, lifestyle factors, and GDM history of the study
participants. GDM cases and controls differed in age, race/ethnicity, education level, prepregnancy BMI, smoking status, and history of GDM. The age range of the GDM cases
was 19-41 years, with the majority (37.5%) aged 30-34 years; the age range for the controls
was 18-44 years, with most (56.5%) below 25 years of age. More than half of the cases had
pre-pregnancy BMI classified as obese (52.4%). Most cases were Hispanic and less likely
to be current smokers compared to the controls. Among the parous women, approximately
one-third of cases had a prior history of GDM (31.0%), which was a higher percentage than
the controls (4.9%) (p < 0.01).
3.2

Urinary concentrations of phenols and parabens

Author Manuscript

The percentage of detectable concentrations, GM (95% CI), and percentiles distribution
of SG-adjusted urinary concentrations of phenols and parabens for cases and controls are
summarized in Table 2. The detection frequency ranged from 93.3% for BPA to 100%
for 2,5-dichlorophenol, except for butylparaben (51.7%) and triclosan (73.2%). The urinary
concentration of BPA was lower among the GDM cases compared to controls [GM (95%
CI): 1.85 (1.51, 2.27) vs. 2.58 (2.29, 2.91) ng/mL, p = 0.01], whereas GDM cases had
higher benzophenone-3 than controls [GM (95% CI): 48.17 (28.25, 82.16) vs. 18.60 (14.89,
23.24) ng/mL, p < 0.01]. Pearson’s correlations between the log-transformed SG-adjusted
urinary concentrations of phenols and parabens are shown in Supplementary Figure 1. There
was a high correlation between 2,4-dichlorophenol and 2,5-dichlorophenol (r = 0.90, p <
0.01). Among the parabens, butylparaben was moderately correlated with methylparaben (r
= 0.32, p < 0.01) and propylparaben (r = 0.34, p < 0.01), while methylparaben was strongly
correlated with propylparaben (r = 0.78, p < 0.01).
3.3

Logistic regression analysis of individual phenols, parabens, and GDM

Author Manuscript

The associations between SG-adjusted urinary concentrations of individual phenols,
parabens, and GDM were evaluated in Table 3. A reduced odds of elevated BPA was
observed in women with GDM (adjusted OR per IQR = 0.61, 95% CI 0.37, 0.99). When
urinary concentrations were categorized into tertiles, the odds of being in the highest BPA
tertile decreased by 51% among cases compared to controls (adjusted OR = 0.49, 95%
0.19, 1.25), though the 95% CI crossed the null. In contrast, benzophenone-3 was positively
associated with GDM (adjusted OR per IQR = 1.54, 95% CI 1.15, 2.08). The odds of having
benzophenone-3 concentrations in the highest tertile were more than three times greater
among the cases than the controls (adjusted OR for the highest benzophenone-3 tertile =
3.82, 95% CI 1.60, 9.08 relative to the lowest tertile). The direction of observed associations
of BPA and benzophenone-3 with GDM remained consistent when stratified by the obesity
status (Supplementary Table 1); however, the stratified estimates lacked precision due to the
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smaller sample size in subgroup analyses. Evidence of associations with GDM were not
observed for triclosan, dichlorophenols, or parabens.
3.4

Probit-BKMR analysis of phenol and paraben mixtures and GDM

Author Manuscript

Figure 1 presents the estimated exposure-response functions of each phenol and paraben and
its 95% CrI. We observed a positive dose-response relationship between benzophenone-3
and GDM, with the probability of GDM increasing with increasing concentrations of
benzophenone-3. Although the relationship between triclosan and GDM was positive
as well, the null was included in the 95% CrI at the highest concentration. BPA and
methylparaben showed inverse relationships with GDM. There was little evidence of the
associations between 2,4-dichlorophenol, 2,5-dichlorophenol, butylparaben, propylparaben,
and GDM. Overall, the CrI was wide in each estimated single exposure-response function,
which represented the high variability of these relationships. Figure 2 displays the
associations of individual phenols and parabens with the estimated GDM probability
difference when fixing all other phenols and parabens concentrations to their 25th, 50th,
and 75th percentiles. We found that an increase in z-score transformed log urinary
concentrations of benzophenone-3 from the 10th to 90th percentile corresponded to a 0.68
(95% CrI 0.0, 1.36), 0.67 (95% CrI 0.04, 1.30), and 0.63 (95% CrI −0.01, 1.28) increase
in the estimated GDM probability when the other phenols and parabens were fixed to their
25th, 50th, and 75th percentiles. However, there was no evidence of GDM associations
for the rest of the phenols and parabens while accounting for the confounding effect
of other phenols and parabens. The estimated overall effect of the phenol and paraben
mixtures on GDM was lacking as the credible intervals for these effect estimates at each
particular percentile of the mixtures crossed the null (Supplementary Figure 2). Additionally,
a potential interaction was observed between benzophenone-3 and methylparaben when
other phenols and parabens were fixed at their median concentrations, with the positive
association between benzophenone-3 and the estimated GDM probability attenuated with
higher concentrations of methylparaben (Supplementary Figure 3). However, the precision
of the product term of benzophenone-3 and methylparaben was limited (p for interaction
= 0.26). The slopes of the other bivariate exposure-response function for a given phenol
or paraben were parallel at different percentiles of the second phenol or paraben, which
indicated no evidence of an interaction.

Author Manuscript
4

Discussion

Author Manuscript

In the present study, we examined the individual and mixture effects of urinary
concentrations of select phenols and parabens on GDM. Using logistic regression models
for assessing each individual chemical biomarker, we determined that benzophenone-3 was
positively associated with GDM, whereas BPA was inversely linked to GDM. However,
using probit-BKMR to consider the correlation among the phenols and parabens examined,
we only consistently observed that higher urinary concentrations of benzophenone-3 were
associated with an increased estimated probability of GDM. In addition, we observed no
evidence of the overall effects of the phenol and paraben mixtures on GDM. To the best
of our knowledge, this study is the first to evaluate the associations of phenol and paraben
mixtures with GDM.
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BPA is a widespread contaminant commonly used in the manufacture of numerous plastic
consumer products made of epoxy resins and polycarbonate (Sargis and Simmons, 2019).
As BPA is an endocrine disruptor that humans are widely exposed to in daily life, the
associations between urinary concentrations of BPA and pregnancy glucose levels and
GDM have been examined in numerous studies; however, findings remain inconsistent.
Among subfertile women in the Environment and Reproductive Health (EARTH) study from
Massachusetts, Chiu et al. (2017) observed a positive association between concentrations
of BPA and glucose levels. In a term birth pregnancy cohort of the LIFECODES study
in Boston, Bellavia et al. (2018) found that BPA concentrations (1.32-2.10 ng/mL) were
associated with higher glucose levels but only among women with obesity. Conversely, in
a Chinese cohort based in Wuhan, Zhang et al. (2019) reported that BPA concentrations
were associated with decreased glucose levels among women with obesity although the
confidence intervals included the null value. By addressing the clinical diagnosis of GDM
as a primary outcome, several studies reported no association between BPA and GDM
(Fisher et al., 2018; Shapiro et al., 2015; Zhang et al., 2019). In a prior assessment of
BPA in a small subset of the same population evaluated for the current study, the observed
odds of GDM were lower with increasing tertiles, but the confidence intervals for these
estimates were wide and included the null value (Robledo et al., 2013). A Chinese cohort
study based in Shanghai reported that the odds of GDM decreased by 27% for per unit
increase in the log-transformed concentrations of BPA (Wang et al., 2017). Additionally,
the odds of GDM for the second (0.82-1.83 ng/mL) and third (1.83-154.60 ng/mL) tertiles
of BPA were lower than that of the lowest tertile (< 0.1-0.82 ng/mL) by 52% and 60%,
respectively. Results from Wang et al. (2017) were consistent with our findings of the
individual exposure models that observed a decreased odds for GDM by 40% per IQR
increase in the log-transformed concentrations of BPA. Although we also observed that the
odds of being in the highest tertile of BPA (3.35-68.19 ng/mL) decreased by 51% in the
cases compared to the controls, this observed association was attenuated and included the
null value. Our study population had slightly higher SG-adjusted urinary concentrations
of BPA (GM: 2.58 ng/mL) than that of the female population in the National Health and
Nutrition Examination Survey (NHANES) 2009-2010 and pregnancy cohorts from the USA,
Canada, and China (GM range: 0.87-1.73 ng/mL) (Bellavia et al., 2018; Centers for Disease
Control and Prevention (CDC), 2022; Chiu et al., 2017; Shapiro et al., 2015; Zhang et
al., 2019). Although different adjustment methods were applied for adjusting the urinary
hydration status, notably the distribution of urinary BPA concentrations in the study by
Wang et al. (2017) [GM (P25, P75) (μg/g creatinine): 2.40 (1.47, 4.36)] was comparable
to that in our study [GM (P25, P75) (SG-adjusted ng/mL): 2.33 (1.42, 4.53)], which may
reflect similar exposure patterns in these populations. In the mixture analysis, we observed
a similar negative trend of the estimated exposure-response function of BPA and GDM as
observed in individual analysis; however, the 95% CrI did not exclude the null value when
increasing BPA concentrations. Findings from an animal study showed that exposure to
BPA may induce increased insulin, leading to the development of chronic hyperinsulinemia
and resulting in the alteration of glucose homeostasis (Alonso-Magdalena et al., 2006). In
gestational animal models, pregnant mice treated with BPA at doses of either 10 or 100
μg/kg/day were associated with decreased glucose tolerance and increased concentrations
of plasma insulin compared to control mice (Alonso-Magdalena et al., 2010). Although
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experimental cell research has demonstrated environmental relevant doses of BPA (1 nM)
can enhance the glucose-induced insulin secretion in human pancreatic islet cells (Soriano et
al., 2012), no other study has evaluated the involvement of environmentally relevant doses
of BPA in the association between a rapid increase in plasma insulin and adverse effects
on glucose metabolism; the possibility of this association needs to be investigated in future
studies.
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Benzophenone-3 is an ultraviolet blocker widely used in sunscreens, cosmetics, and personal
care products, and plastic surface coatings for food packaging (Dodson et al., 2020). Few
epidemiological studies have examined the association between exposure to benzophenone-3
and GDM. Among subfertile women in the EARTH study, Wang et al. (2020) reported
an inverse association between first-trimester urinary concentrations of benzophenone-3
and glucose levels. This study additionally found that the odds of impaired glucose
tolerance (GCT ≥ 140 mg/dL) decreased by 88% among women with second-trimester
benzophenone-3 in the third quartile (170.7-811.8 ng/mL) compared to women in the
lowest quartile (< LOD-36.3 ng/mL). However, one study from the United Kingdom (UK)
reported a null association between the serum concentrations of benzophenone-3 and GDM
(Fisher et al., 2018). Inconsistent with previous findings, our results showed a positive
association between benzophenone-3 and GDM in the individual exposure biomarkers
analysis. This positive association was consistently observed when accounting for the
effect of other phenols and parabens in our mixture analysis. The inconsistency between
our results and those of previous studies may relate to the differences in distribution of
urinary benzophenone-3 concentrations in the study populations. The women in our study
population exhibited slightly lower urinary concentrations of benzophenone-3 compared to
the female population in NHANES 2009-2010 (GM: 18.60 vs. 32.0 ng/mL) (Centers for
Disease Control and Prevention (CDC), 2022). However, in the EARTH cohort, the urinary
concentrations of benzophenone-3 found in subfertile women during preconception and
first- and second-trimesters were approximately 8-fold higher than those found in our study
population (Wang et al., 2020). With substantially higher concentrations of benzophenone-3
in the EARTH study, their referent group (lowest quartile: < LOD-36.3 ng/mL) was
characterized by relatively higher concentrations than the referent group representing low
exposure in our study population (< LOD-7.40 ng/mL). Prior studies have found that
benzophenone-3 was associated with altered thyroid hormone levels (Aker et al., 2018)
and increased oxidative stress (Ferguson et al., 2019) during pregnancy, contributing to
adverse pregnancy outcomes. Evidence from an in vivo study showed that female rats
administered with benzophenone-3 dermally during pregnancy had increased extracellular
glutamate concentration and enhanced lipid peroxidation (Skórkowska et al., 2020). Both
extracellular glutamate and lipid peroxidation play an important role in the pathogenesis
of diabetes (Takahashi et al., 2019; Tangvarasittichai, 2015). Another gestational animal
study found that exposure to benzophenone-3 may lead to dysregulation of metabolites
in the tricarboxylic acid cycle, followed by increased xanthurenic acid levels and an
impact on glucose homeostasis (Han et al., 2022). Additional animal studies are warranted
to understand the mechanism underlying the effect of benzophenone-3 on the abnormal
changes in pregnancy glucose levels.
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Triclosan is a chlorinated antimicrobial chemical that has been widely used in personal
care products such as hand washes, toothpaste, and deodorants (Dodson et al., 2020).
Experimental studies using gestational animal models have shown that the activity of
placental glucose transporters and serum thyroxine levels were reduced, leading to insulin
resistance, in pregnant mice exposed to a high dose of triclosan (8 mg/kg/day) compared to
that in the control mice (Cao et al., 2017; Hua et al., 2017). A recent study demonstrated
that exposure to triclosan during pregnancy was associated with increased oxidative stress
among US pregnant women (Ferguson et al., 2019). Epidemiological studies evaluating the
effect of triclosan on GDM are limited. We found limited evidence of association between
the urinary concentrations of triclosan and GDM in individual exposure analysis, which
is consistent with the results from Canadian and Chinese studies (Ouyang et al., 2018;
Shapiro et al., 2018). Although we observed a positive relationship between the estimated
exposure-response function of triclosan and GDM in our mixture analysis, the width of the
95% credible interval increased with increasing concentration and did not exclude the null
value. However, this result contradicted the findings of a study from the UK that observed
an inverse association between the serum concentrations of triclosan and GDM (Fisher et
al., 2018). The discrepancy between these results may be because triclosan was assessed
using different matrices. As non-persistent chemicals metabolize quickly in the human body,
the levels of their hydrophilic metabolites in the blood are substantially lower than in
urine (Calafat et al., 2013). The low levels measured in the blood are more susceptible to
extraneous sources and may not reflect actual daily habits of exposure (Calafat et al., 2013).
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2,4-Dichlorophenol and 2,5-dichlorophenol, which are used in herbicides and pesticides,
can be found in contaminated drinking water and may be linked to immunotoxicity
or carcinogenicity (Dodson et al., 2020). Pregnant women with high concentrations of
2,4-dichlorophenol and 2,5-dichlorophenol have been found to have increased oxidative
stress and changes in thyroid hormone levels (Aker et al., 2018; Berger et al.,
2018; Ferguson et al., 2019). In our study, we observed no association between
2,4-dichlorophenol, 2,5-dichlorophenol, and GDM. Only one study has evaluated the
associations of urinary concentrations of 2,4-dichlorophenol and 2,5-dichlorophenol with
diabetes-related outcomes. Results of a cross-sectional study using data from the 2007-2010
NHANES showed a positive dose-dependent association between increasing quartiles of 2,5dichlorophenol and T2DM, and no association was found between 2,4-dichlorophenol and
T2DM (Wei and Zhu, 2016). However, this study was conducted in the general population
instead of pregnant women. Additional studies can help better understand the potential
impact of 2,4-dichlorophenol and 2,5-dichlorophenol in dysglycemia during pregnancy and
its mechanisms.
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Parabens are a group of esters of p-hydroxybenzoic acid with alkyl substituents that are
extensively used as preservatives in personal care products, cosmetics, pharmaceuticals,
and food (Błędzka et al., 2014; Dodson et al., 2020). Parabens can potentially impact
glucose homeostasis through specific mechanisms. Through operating as estrogenic EDCs,
parabens may alter hormone signaling (van Meeuwen et al., 2008). In addition, parabens
may stimulate adipocytes to release leptin and adiponectin and affect the adipogenic
effect by activating PPARs (Taxvig et al., 2012). Certain parabens were also associated
with decreased thyroid hormone levels and increased oxidative stress among pregnant
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women (Aker et al., 2018; Berger et al., 2018; Ferguson et al., 2019). Among subfertile
women in the EARTH study, glucose levels increased with higher urinary concentrations
of propylparaben and butylparaben when all parabens were mutually adjusted in the same
model (Bellavia et al., 2019). However, according to our individual exposure biomarker
analysis, butylparaben, methylparaben, and propylparaben showed no association with
GDM, which is in accordance with the results of two Chinese studies conducted in
Wuhan (Li et al., 2019; Liu et al., 2019). Our mixture analysis observed an inverse
relationship between the estimated exposure-response function of methylparaben and GDM,
but the credible intervals crossed the null. The differences in the exposure biomarkers
concentrations may be a potential reason for these inconsistent results among studies.
The urinary concentrations of methylparaben and propylparaben in our study (GM for
methylparaben: 169.93; for propylparaben: 27.81 ng/mL) were higher than those determined
in the NHANES and the cohorts of the studies in Wuhan and the EARTH study (GM
range for methylparaben: 5.54-124.1; for propylparaben: 0.49-25.3 ng/mL) (Bellavia et al.,
2019; Centers for Disease Control and Prevention (CDC), 2022; Li et al., 2019; Liu et al.,
2019). Thus, the referent group of lowest tertile in our study would represent relatively
higher concentrations than in the Wuhan and the EARTH studies and does not similarly
assess the dose-response relationship between methylparaben, propylparaben, and GDM
when compared to these lower exposure biomarker concentrations.
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Several methodological considerations need to be considered when comparing our results
with those of other studies. Chemical exposure assessment in different trimesters may be a
possible reason for inconsistent results in studies evaluating the associations of phenols and
parabens with GDM. Using the data from the EARTH pregnancy cohort, Chiu et al. (2017)
assessed BPA exposure in different trimesters of urine specimens to determine the timing of
exposure in relation to blood glucose levels. They observed that increased second-trimester
BPA concentrations were associated with evaluated glucose levels. However, no association
was found between BPA and glucose levels when measuring biomarkers concentrations in
the first-trimester (weeks 1-12). These findings suggest that the second-trimester (weeks
13-26) may be the etiologically relevant time window during which susceptibility to
BPA exposures may be related to the pregnancy glucose levels (Chiu et al., 2017). Our
study quantified the urinary concentrations of phenols and parabens at the clinical visit
immediately following glucose screening during mid-pregnancy. Therefore, the timing of
our exposure assessment may have occurred outside the etiologically relevant window for
GDM.
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The evaluation of the different outcomes for dysglycemia during pregnancy may lead
to discrepant results across studies. Several previous studies assessed the association of
phenol and paraben exposures with non-fasting GCT glucose levels because they were
underpowered with a limited number of GDM events (Bellavia et al., 2018; Bellavia et
al., 2019; Chiu et al., 2017; Wang et al., 2020). These studies also evaluated GCT glucose
as a binary outcome, which categorized GCT ≥ 140 mg/dL as an indicator of impaired
glucose tolerance. Non-fasting GCT can be influenced by the timing of meals and testing
(Gupta et al., 2015). Thus, using non-fasting GCT to evaluate impaired glucose tolerance
may be more susceptible to misclassification errors. Although our study used the clinical
diagnosis of GDM as a primary outcome, it does not exclude some women who may have
Environ Res. Author manuscript; available in PMC 2022 November 01.
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glucose levels that are higher than normal glucose but not high enough to be diagnosed
as GDM (pre-diabetes). Additionally, GDM case identification in our study did not apply
the more recent diagnostic criteria adopted by the International Association of Diabetes
and Pregnancy Study Groups (IADPSG) (Metzger et al., 2010) because these criteria had
not been adopted when our participants were being tested for GDM. When applying the
diagnosis criteria by IADPSG, only a single-step OGTT is performed and single abnormal
OGTT values are defined as GDM. Thus, cases of GDM may have been missed when using
the former two-step approach requiring two or more OGTT values exceeding thresholds.
In our study, there were 41 women in the control group who exhibited GCT > 135 mg/dL
during the initial screening. After prompting referral of these women for a diagnostic
OGTT, only 7 of these women presented a single abnormal value on the 3-hour OGTT.
The inclusion of these women with pre-diabetes in the control group may bias observed
associations toward the null; however, the numbers of women with pre-diabetes are limited.
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Few studies to date have accounted for the confounding effect due to exposure to other
related chemicals in the analysis of associations between phenols, parabens, and GDM. In
the present study, we observed that certain phenols and parabens were highly correlated with
their related chemicals; thus, multicollinearity may be present when including all chemical
biomarkers in the linear or logistic regression models at the same time. Multicollinearity
would influence regression estimates and bias standard errors (Vatcheva et al., 2016). Using
data from the EARTH pregnancy cohort, Bellavia et al. (2019) evaluated the association of
exposure to three parabens (methylparaben, propylparaben, and butylparaben) and glucose
levels measured by GCT using multiple linear regression and BKMR models. This study
reported that the first-trimester urinary concentrations of propylparaben were not associated
with glucose levels in the individual paraben model. While mutually adjusting all parabens
in the same model, increased propylparaben concentrations were significantly associated
with a decreased glucose level with extremely wide confidence intervals. No statistically
significant association was observed when further analyzing parabens as a mixture in the
BKMR model. These inconsistent results of individual, mutually adjusted, and BKMR
models demonstrated the adverse impact of multicollinearity on the estimate and precision
of the linear regression model. Our study employed BKMR with a hierarchical variable
selection approach to model multiple chemicals and GDM. Thereby, we accounted for the
confounding effect across other highly correlated chemicals and avoided multicollinearity
and model misspecification, which cannot be handled through the traditional parametric
regression approach (Bobb et al., 2018; Bobb et al., 2015; Valeri et al., 2017). So far,
limited studies have assessed the nonlinear association between phenols, parabens, and
GDM. Using restricted cubic splines, Li et al. (2019) and Liu et al. (2019) identified the
possible nonlinear association between the urinary concentrations of parabens and GDM.
Zhang et al. (2019) reported a U-shaped association between the urinary concentrations
of BPA and glucose levels, as measured using OGTT. In line with previous studies, we
observed non-monotonic associations of BPA and triclosan with the estimated difference in
the probability of GDM when evaluated using probit-BKMR models. These results suggest
that the traditional regression method with the assumption of linearity may not correctly
describe the exposure-response functions when evaluating the association of phenol and
paraben exposures with GDM. Using BKMR in our study, we captured the presence of a
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complex nonlinear exposure-response function while fixing other chemical biomarkers at
certain concentrations and explored the jointed effect of the chemicals. Our study highlights
the importance of evaluating the effect of phenols as a mixture using BKMR in studies of
multiple perinatal environmental exposures.
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This study expanded the scope of evidence evaluating the association between phenols,
parabens, and GDM using a mixture analysis of probit-BKMR. However, it is necessary
to consider several limitations when interpreting these results. The relatively small sample
size of our study is a major limitation, which limited statistical power, precision of point
estimates, and our ability to simultaneously evaluate multiple potential confounders in the
multivariable models. Additionally, it is possible that our observed associations may have
been impacted by potential selection bias due to unknown selection factors. Our study
restricted the population to patients residing in the counties surrounding the clinic to ensure
that controls were selected from the source population that provided the cases. We cannot,
however, rule out the possibility that potential selection bias may exist if the exposure
distribution of the controls failed to represent the source population. We assessed the urinary
concentrations of phenols and parabens using a single spot urine sample. As phenols and
parabens are rapidly metabolized and excreted from the body and urinary concentrations
are known to vary throughout pregnancy (Vernet et al., 2018), the measurements of
urinary concentrations would primarily reflect exposures in the days immediately before
specimen collection. Several prior studies assessed the variability of urinary phenols and
parabens during pregnancy and reported that certain chemicals had moderate reliability, with
intraclass correlation coefficients (ICC) ranging from 0.62 to 0.70 for benzophenone-3, 0.58
to 0.61 for triclosan, 0.56 to 0.64 for butylparaben, 0.44 to 0.61 for methylparaben, and
0.54 to 0.56 for propylparaben (Braun et al., 2012; Philippat et al., 2013; Yazdy et al.,
2018), except for BPA with rather low ICC ranging from 0.11 to 0.31 (Casas et al., 2018).
This suggests that a single urine sample may be reasonable to assess individual exposure to
most phenols and parabens. Nevertheless, concentrations of urinary phenols and parabens
may also be potentially influenced by the time of urine collection and non-fasting status.
Since sample collection occurred across morning and afternoon clinic visits, variation in
time of day can be considered another limitation of the use of single spot urine samples to
assess exposure. Thus, we cannot rule out the possibility of measurement error due to the
variability of urinary concentrations that may result in attenuation or inflation of the true
association. Considering that changes in placental and maternal hormones over the course
of pregnancy are involved in the development of maternal insulin resistance (Newbern
and Freemark, 2011), future research with multiple urine biomarker measurements during
pregnancy will improve exposure assessment and help elucidate the sensitive windows of
environmental chemical exposures and GDM. In addition, the detection frequency of certain
parabens (i.e., butylparaben) was relatively low in this study. We substituted a value equal to
the LOD/√2 for concentrations less than the LOD, which may be prone to biased estimation.
However, this substitution makes little difference in the geometric mean estimate if the
detection frequency is above 40% (Centers for Disease Control and Prevention (CDC),
2022). Furthermore, our study was unable to account for unmeasured factors such as diet
and physical activity (Mijatovic-Vukas et al., 2018). Diet is a recognized health-related
factor during pregnancy and is a primary source of exposure to certain phenols (Pacyga et
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al., 2019). Detailed dietary components and patterns should be obtained in future studies to
consider the role of diet in the observed association. Lastly, since the specimen collection
in this case-control study design occurred at the clinical visit following glucose screening,
the temporality of the relationship between the environmental phenols and parabens and
GDM cannot be established. Moreover, due to this limitation, it is possible that the urinary
concentrations of chemical biomarkers may have been affected by GDM development.

5

Conclusions
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In this case-control study among pregnant women in Oklahoma, a positive association
between the urinary concentrations of benzophenone-3 and GDM was observed either
assessed individually or evaluated as a mixture, while accounting for other phenols and
parabens. This study applied a novel statistical framework for evaluating the effect of
exposure to multiple phenols and parabens on GDM. An inverse association was observed
between urinary concentrations of BPA and GDM in the individual exposure biomarker
model, but this association was attenuated and included the null when addressing phenol and
paraben mixtures in the analysis. The differences in the effects of individual chemicals and
chemical mixtures revealed the importance of accounting for correlation among the chemical
mixture components in studies on the relationship between perinatal environmental exposure
and pregnancy complications, given women are exposed to multiple chemicals. Future
prospective studies involving repeated biospecimen collection and fasting glucose measures
during different windows of exposure throughout pregnancy may provide insights on the
strength of evidence for a causal relationship between phenol and paraben exposure and
pregnancy dysglycemia. Additional prospective investigations are warranted for verifying
the link between benzophenone-3 exposure and GDM.
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Figure 1. The estimated single exposure-response functions and 95% CrI for each phenol and
paraben when all other phenols and parabens were fixed at their median levels.

The probit-BKMR model was adjusted for specific gravity, age, race/ethnicity, education
level, pre-pregnancy BMI, and history of GDM.
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Figure 2. The estimated effect and 95% CrI of each phenol and paraben on GDM when each
phenol and paraben was increased from the 10th to the 90th percentile of its distribution while
other phenols and parabens were fixed to their 25th, 50th, or 75th percentile.

The probit-BKMR model was adjusted for specific gravity, age, race/ethnicity, education
level, pre-pregnancy BMI, and history of GDM.
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Distribution of demographics, lifestyle factors, and GDM history for cases and controls.
Variables

Cases (n = 64)
n (%)

Controls (n = 237)
n (%)

< 25

18 (28.1)

134 (56.5)

25 – 29

12 (18.8)

63 (26.6)

30 – 34

24 (37.5)

24 (10.1)

≥ 35

10 (15.6)

16 (6.8)

Maternal age (years)

< 0.01

Author Manuscript

Non-Hispanic White

16 (25.0)

70 (29.7)

Non-Hispanic Black

6 (9.4)

79 (33.4)

Hispanic

40 (62.5)

70 (29.7)

Native American

2 (3.1)

17 (6.8)

Asian

0

1 (0.4)

Educational level

0.02

Less than high school

32 (50.0)

73 (30.8)

High school

18 (28.1)

89 (37.6)

14 (21.9)

75 (31.7)

More than high school
Pre-pregnancy BMI (kg/m2)

a

< 0.01

Normal (≤ 24.99)

13 (20.6)

107 (45.5)

Overweight (25.0-29.99)

17 (27.0)

52 (22.1)

Obese (≥ 30.0)

33 (52.4)

76 (32.3)

Alcohol consumption

0.65

Author Manuscript

No

58 (90.6)

210 (88.6)

Yes

6 (9.4)

27 (11.4)

c

0.04

No

55 (85.9)

175 (73.8)

Yes

9 (14.1)

62 (26.2)

Self-reported history of GDM

a

c

< 0.01

Race/Ethnicity

Active smoker

P-value

< 0.01

Nulliparous

13 (20.3)

55 (23.2)

Parous without GDM history

35 (54.7)

173 (73.0)

Parous with GDM history

16 (25.0)

9 (3.8)

Pre-pregnancy BMI data were missing for one case and two controls.

b

Self-reported current smoking status or urinary cotinine levels ≥ 15 ng/mL for active smokers.

c

Author Manuscript

P-value based on the Chi-square test.
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99.7
73.2
93.6
100

Triclosan

2,4-Dichlorophenol

2,5-Dichlorophenol

99.3
99.0

Methylparaben

Propylparaben

a

26.78 (16.36, 43.84)

132.43 (92.91, 188.80)

0.61 (0.40, 0.95)

19.04 (11.36, 31.89)

1.68 (1.15, 2.44)

18.04 (10.55, 30.83)

48.17 (28.25, 82.16)

1.85 (1.51, 2.27)

53.53

167.0

0.33

10.62

1.20

13.72

31.45

2.05

102.04

325.12

2.61

42.21

2.17

136.24

225.65

2.91

27.81 (21.58, 35.82)

169.93 (139.60, 206.80)

0.65 (0.52, 0.83)

20.47 (16.02, 26.15)

1.54 (1.29, 1.84)

11.89 (9.59, 14.75)

18.60 (14.89, 23.24)

2.58 (2.29, 2.91)

7.21

69.58

0.16

5.10

0.65

3.13

5.88

1.42

P25

35.75

193.56

0.36

13.44

1.15

9.16

12.62

2.33

P50

119.88

524.90

1.87

47.24

2.37

35.20

36.64

4.53

P75

0.89

0.24

0.80

0.79

0.67

0.15

< 0.01

0.01

P-value

b

P-value from Student’s t-test of the arithmetic means of the log-transformed values between cases and controls.

b

The limits of detection were 0.2 (2,4-dichlorophenol, 2,5-dichlorophenol, butylparaben, and propylparaben), 0.4 (BPA and benzophenone-3), 1.0 (methylparaben), and 2.3 (triclosan) ng/mL.

a

Three subjects (1 case and 2 controls) were removed from analysis as missing for pre-pregnancy BMI.

7.08

76.37

0.13

3.62

0.72

2.78

9.71

1.04

GM (95% CI)

P75

Controls
P50

GM (95% CI)

P25

Cases

Abbreviations: SG, specific gravity; GM, geometric mean; CI, confidence interval.

51.7

Butylparaben

Parabens

93.3

Benzophenone-3

Detection frequency (%)

Bisphenol A

Phenols

Chemicals

The percentage of detectable concentrations, geometric mean (ng/mL) and distribution percentiles of SG-adjusted urinary concentrations (ng/mL) of
phenols and parabens for cases and controls (2009-2010).
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Associations between SG-adjusted urinary concentrations of phenols, parabens, and GDM.
Phenols and parabens
(ng/mL)

Cases
n (%)

Controls
n (%)

Crude OR
a
(95% CI)

Adjusted OR
b
(95% CI)

0.60 (0.40, 0.89)

0.61 (0.37, 0.99)

Bisphenol A
Per IQR
≤ 1.66

25 (39.7)

78 (33.2)

1.00

1.00

1.67 – 3.34

26 (41.3)

78 (33.2)

1.05 (0.56, 1.98)

1.03 (0.49, 2.17)

≥ 3.35

12 (19.0)

79 (33.6)

0.48 (0.22, 1.03)

0.49 (0.19, 1.25)

P trend = 0.08

P trend = 0.18

Benzophenone-3
Per IQR

1.57 (1.22, 2.03)

1.54 (1.15, 2.08)

Author Manuscript

≤ 7.40

11 (17.5)

78 (33.2)

1.00

1.00

7.41– 22.0

14 (21.2)

78 (33.2)

1.28 (0.55, 3.03)

1.20 (0.44, 3.23)

≥ 22.01

38 (60.3)

79 (33.6)

3.41 (1.63, 7.15)

3.82 (1.60, 9.08)

P trend < 0.01

P trend < 0.01

Triclosan
Per IQR

1.36 (0.94, 1.97)

1.41 (0.93, 2.13)

≤ 4.71

24 (38.1)

78 (33.2)

1.00

1.00

4.72 – 22.68

15 (23.8)

78 (33.2)

0.62 (0.30, 1.27)

0.66 (0.28, 1.53)

≥ 22.69

24 (38.1)

79 (33.6)

1.00 (0.52, 1.90)

1.14 (0.54, 2.42)

P trend = 0.99

P trend = 0.75

2,4-Dichlorophenol
Per IQR

1.06 (0.83, 1.35)

1.06 (0.80, 1.41)

Author Manuscript

≤ 0.80

18 (28.6)

78 (33.2)

1.00

1.00

0.81 – 1.83

29 (46.0)

78 (33.2)

1.63 (0.84, 3.18)

1.98 (0.90, 4.36)

≥ 1.84

16 (25.4)

79 (33.6)

0.88 (0.42, 1.85)

1.03 (0.44, 2.43)

P trend = 0.75

P trend = 0.91

2,5-Dichlorophenol
Per IQR

0.96 (0.68, 1.35)

0.92 (0.61, 1.37)

≤ 6.65

25 (39.7)

78 (33.2)

1.00

1.00

6.66 – 31.69

18 (28.6)

78 (33.2)

0.71 (0.36, 1.41)

0.80 (0.36, 1.81)

≥ 31.70

20 (31.7)

79 (33.6)

0.79 (0.41, 1.54)

0.78 (0.35, 1.76)

P trend = 0.48

P trend = 0.55

Butylparaben
Per IQR

0.94 (0.63, 1.40)

1.16 (0.73, 1.85)

Author Manuscript

Non-detectable

33 (52.4)

111 (47.2)

1.00

1.00

≤ 1.81

13 (20.6)

62 (26.4)

0.72 (0.35, 1.47)

0.96 (0.41, 2.24)

≥ 1.82

17 (27.0)

62 (26.4)

0.93 (0.48, 1.81)

1.53 (0.68, 3.43)

P trend = 0.73

P trend = 0.34

Methylparaben
Per IQR

0.81 (0.56, 1.17)

0.83 (0.53, 1.29)
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Cases
n (%)

Controls
n (%)

Crude OR
a
(95% CI)

Adjusted OR
b
(95% CI)

≤ 102.55

21 (33.3)

78 (33.2)

1.00

1.00

102.56 – 383.74

30 (47.6)

78 (33.2)

1.43 (0.75, 2.71)

1.35 (0.63, 2.85)

≥ 383.75

12 (19.1)

79 (33.6)

0.57 (0.26, 1.23)

0.58 (0.24, 1.39)

P trend = 0.20

P trend = 0.28

Propylparaben
Per IQR

0.97 (0.66, 1.46)

1.13 (0.70, 1.83)

≤ 14.12

20 (31.7)

78 (33.2)

1.00

1.00

14.13 – 79.22

20 (31.7)

78 (33.2)

1.00 (0.50, 2.00)

1.13 (0.49, 2.60)

≥ 79.23

23 (36.6)

79 (33.6)

1.15 (0.58, 2.26)

1.54 (0.69, 3.46)

P trend = 0.69

P trend = 0.29

Abbreviations: SG, specific gravity; OR, odds ratio; CI, confidence interval.
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a
Adjusted for specific gravity.
b

Adjusted for specific gravity, age, race/ethnicity, education level, pre-pregnancy BMI, and history of GDM.
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